Inhibitor-Immunology-Study: Evaluation of inhibitor development in haemophilia B

Hamostaseologie

Volumn 31, Issue SUPPL.1, 2011, Pages

  Wieland, I ^a   Wermes, C ^a   Eifrig, B ^b   Holstein, K ^b   Pollmann, H ^c   Siegmund, B ^c   Eberl, W ^d   Kemkes Matthes, B ^e   Bidlingmaier, C ^f   Kurnik, K ^f   Lischetzki, G ^g   Nimtz Talaska, A ^h   Eisert, R ^a   Bogdanova, N ⁱ   Doerk, T ^a   Sykora, K W ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c Institut für Thrombose und Hämostaseologie   (Germany)

^d KLINIKUM BRAUNSCHWEIG   (Germany)

^e JUSTUS LIEBIG UNIVERSITY   (Germany)

^f Haunersche Klinik   (Germany)

^g UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^h Klinikum Frankfurt Oder   (Germany)

ⁱ UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Haemophilia B; HLA; Inhibitor; SNPs

Indexed keywords

BLOOD CLOTTING INHIBITOR; CD40 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DPB1 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HEMOPHILIA B; HLA TYPING; HUMAN; POPULATION RESEARCH; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; STUDENT T TEST; TREND STUDY; BLOOD; FEMALE; GENE; GENETIC PREDISPOSITION; GENETICS; MALE; PRESCHOOL CHILD;

ADOLESCENT; BLOOD COAGULATION FACTOR INHIBITORS; CHILD; CHILD, PRESCHOOL; FEMALE; GENES, MHC CLASS II; GENETIC PREDISPOSITION TO DISEASE; HEMOPHILIA B; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84859243221     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1619751     Document Type: Article

References (11)

1. Aly AM, Aledort LM, Lee TD, Hoyer LW. Histocompatibility antigen patterns in haemophilic patients with factor VIII antibodies. Br J Haematol 1990; 76: 238-241.
2. Astermark J, Oldenburg J, Pavlova A et al. for the MIBS Study Group. Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A. Blood 2006; 107: 3167-3172.
3. Astermark J, Oldenburg J, Carlson J et al. Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A. Blood 2006; 108: 3739-3745.
4. Astermark J, Wang X, Oldenburg J et al. on behalf of the MIBS Study group. Polymorphisms in the CTLA-4 gene and inhibitor development in patients with sever hemophilia A. J Thromb Haemost 2007; 5: 263-265.
5. Hay CR, Ollier W, Pepper L et al. HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working Party. Thromb Haemost 1997; 77: 234-237.
6. Lippert LE, Fisher LM, Schook LB. Relationship of major histocompatibility complex class II genes to inhibitor antibody formation in hemophilia A. Thromb Haemost 1990; 64: 564-568.
7. Mayr WR, Lechner K, Niessner H, Pabinger-Fasching I. HLA-DR and Factor VIII antibodies in hemophilia A. Thromb Haemost 1984; 51: 293.
8. Oldenburg J, Picard JK, Schwaab R et al. HLA genotype of patients with severe haemophilia A due to intron 22 inversion with and without inhibitors of factor VIII. Thromb Haemost 1997; 77: 238-242.
9. Ohta H, Takahashi I, Kojima T et al. Histocompatibility antigens and alleles in Japanese haemophilia A patients with or without factor VIII antibodies. Tissue Antigens 1999; 54: 91-97.
10. Schwaab R, Brackmann HH, Meyer C et al. Haemophilia A: mutation type determines risk of inhibitor formation. Thromb Haemost 1995; 74: 1402-1406.
11. Wieland I, Wermes C, Eifrig B et al. Inhibitor-Immunology-Study: Different HLA-types seem to be involved in the inhibitor development in haemophilia A. Hämostaseologie 2008; 28 (Suppl): 26-28.